← Back to Screener
Retractable Technologies, Inc (RVP)
Price$0.69
Favorite Metrics
Price vs S&P 500 (26W)-29.18%
Price vs S&P 500 (4W)-7.51%
Market Capitalization$20.20M
All Metrics
Book Value / Share (Quarterly)$2.48
P/TBV (Annual)5.17x
Revenue Growth (3Y)-26.10%
Cash Flow / Share (Quarterly)$-0.25
Payout Ratio (TTM)2.78%
Price vs S&P 500 (YTD)-13.27%
Gross Margin (TTM)0.12%
Net Profit Margin (TTM)-32.84%
EPS (TTM)$-0.42
10-Day Avg Trading Volume0.08M
EPS Excl Extra (TTM)$-0.42
Revenue Growth (5Y)-14.12%
EPS (Annual)$-0.42
Dividend / Share (Annual)$0.01
ROI (Annual)-16.63%
Gross Margin (Annual)4.83%
Net Profit Margin (5Y Avg)-9.95%
Cash / Share (Quarterly)$1.24
Revenue Growth QoQ (YoY)4.03%
ROA (Last FY)-8.81%
Revenue Growth TTM (YoY)15.78%
EBITD / Share (TTM)$-0.19
ROE (5Y Avg)4.75%
Operating Margin (TTM)-50.37%
Cash Flow / Share (Annual)$-0.25
P/B Ratio0.27x
P/B Ratio (Quarterly)0.31x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.48x
Net Interest Coverage (TTM)-1.44x
ROA (TTM)-8.58%
EV / EBITDA (TTM)16.53x
EPS Incl Extra (Annual)$-0.42
Current Ratio (Annual)6.57x
Quick Ratio (Quarterly)4.78x
3-Month Avg Trading Volume0.05M
52-Week Price Return-1.69%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.00
P/S Ratio (Annual)0.53x
Asset Turnover (Annual)0.27x
52-Week High$1.14
Operating Margin (5Y Avg)-20.45%
EPS Excl Extra (Annual)$-0.42
CapEx CAGR (5Y)-52.01%
Tangible BV CAGR (5Y)-5.61%
26-Week Price Return-25.20%
Quick Ratio (Annual)4.78x
13-Week Price Return-9.45%
Total Debt / Equity (Annual)0.02x
Current Ratio (Quarterly)6.57x
Enterprise Value$18.509
Revenue / Share Growth (5Y)-12.27%
Asset Turnover (TTM)0.26x
Book Value / Share Growth (5Y)11.10%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.00x
Pretax Margin (Annual)-32.08%
Cash / Share (Annual)$1.24
3-Month Return Std Dev51.49%
Gross Margin (5Y Avg)20.62%
Net Income / Employee (TTM)$-0
ROE (Last FY)-16.89%
Net Interest Coverage (Annual)-0.87x
EPS Basic Excl Extra (Annual)$-0.42
P/FCF (TTM)2.15x
Receivables Turnover (TTM)4.88x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-0.42
Receivables Turnover (Annual)4.88x
ROI (TTM)-16.30%
Dividend Growth Rate (5Y)3.13%
P/S Ratio (TTM)0.53x
Pretax Margin (5Y Avg)-3.58%
Revenue / Share (Annual)$1.28
Tangible BV / Share (Annual)$0.96
Price vs S&P 500 (52W)-31.52%
Year-to-Date Return-10.62%
5-Day Price Return-4.15%
EPS Normalized (Annual)$-0.42
ROA (5Y Avg)1.94%
Net Profit Margin (Annual)-32.84%
Month-to-Date Return4.27%
Cash Flow / Share (TTM)$-0.13
EBITD / Share (Annual)$-0.19
Operating Margin (Annual)-50.37%
LT Debt / Equity (Annual)0.01x
ROI (5Y Avg)4.61%
LT Debt / Equity (Quarterly)0.01x
EPS Basic Excl Extra (TTM)$-0.42
P/TBV (Quarterly)2.56x
P/B Ratio (Annual)0.31x
Dividend / Share (TTM)$0.01
Inventory Turnover (TTM)2.10x
Pretax Margin (TTM)-32.08%
Book Value / Share (Annual)$2.48
Price vs S&P 500 (13W)-10.13%
Dividend Yield (TTM)1.14%
Beta1.36x
P/FCF (Annual)10.56x
Revenue / Share (TTM)$1.28
ROE (TTM)-16.52%
52-Week Low$0.62
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
RVPRetractable Technologies, Inc | 0.53x | -14.12% | 0.12% | -50.37% | $0.69 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Retractable Technologies develops and manufactures safety-engineered syringes and injection systems for healthcare providers. Its branded products, including VanishPoint syringes and blood collection systems, emphasize needle safety features designed to reduce needlestick injuries. The company serves both U.S. and international markets with a focus on healthcare worker protection.